Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/12805
Title: | Trochlear pain: clinical characteristics and treatment outcomes |
Authors: | Chanlalit W. Teeyapant C. Soodchuen S. |
Keywords: | dexamethasone diclofenac ibuprofen indometacin lidocaine naproxen nonsteroid antiinflammatory agent steroid adult aged Article Brown syndrome clinical article diplopia ecchymosis eye movement female follow up headache human idiopathic disease male medical record review middle aged migraine nausea pain photophobia priority journal remission retrospective study symptom tension headache treatment outcome trochlear pain trochlear pain trochleitis very elderly young adult analgesia complication computed tomography scanner diagnostic imaging orbit pain pain measurement procedures treatment outcome trochlear nerve disease Anti-Inflammatory Agents, Non-Steroidal Female Humans Male Middle Aged Orbit Pain Pain Management Pain Measurement Retrospective Studies Steroids Tomography Scanners, X-Ray Computed Treatment Outcome Trochlear Nerve Diseases |
Issue Date: | 2018 |
Abstract: | Trochlear pain is frequently overlooked as published data regarding the clinical characteristic and current treatment are limited. The aim of this study is to evaluate this information from our experiences with trochlear pain. Medical records of 43 patients with trochlear pain from HRH Princess Maha Chakri Sirindhorn Medical Center between November 2010 and April 2017 were reviewed. Most patients were female (88%), with a median age of 51 years. Common characteristic symptoms of trochlear pain were acute, episodic, dull or pressure-like, periorbital pain, often radiating to the forehead, and aggravated by eye movements, especially reading. The causes of trochlear pain were idiopathic or primary trochlear headache (n = 33, 77%) and trochleitis (n = 10, 23%). Treatments included oral NSAIDs or dexamethasone injection into the trochlear region. At a median follow-up of 11 months (range 0–64), 67% of the patients reported complete remission using oral medication. Local steroid injection is useful in non-responding patients to oral therapy with an overall remission of 86%. Successful treatment outcome was achieved in most patients. © 2017, Springer-Verlag GmbH Germany, part of Springer Nature. |
URI: | https://ir.swu.ac.th/jspui/handle/123456789/12805 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038406648&doi=10.1007%2fs00415-017-8713-7&partnerID=40&md5=111fdd0d1a9503e93b77dc38f5e238d0 |
ISSN: | 3405354 |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.